COVID-19 Impact on Global Multiple Sclerosis Drugs Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: C70248D0EA8AEN
QYResearch

Abstracts

This report focuses on the global Multiple Sclerosis Drugs Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Sclerosis Drugs Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Roche
• Biogen
• Teva Pharmaceutical
• Merck
• Novartis
• Bayer
• Sanofi
• Acorda Therapeutics
• Questcor Pharmaceuticals
• AbbVie
• Opexa Therapeutics
• Genzyme Corporation

Market segment by Type, the product can be split into

• Interferon
• Immunomodulator
• Immunosuppressant

Market segment by Application, split into

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Multiple Sclerosis Drugs Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Multiple Sclerosis Drugs Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Multiple Sclerosis Drugs Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Multiple Sclerosis Drugs Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Interferon
  1.4.3 Immunomodulator
  1.4.4 Immunosuppressant
1.5 Market by Application
  1.5.1 Global Multiple Sclerosis Drugs Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacy
  1.5.3 Retail Pharmacy
  1.5.4 Online Pharmacy
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Multiple Sclerosis Drugs Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Multiple Sclerosis Drugs Treatment Industry
    1.6.1.1 Multiple Sclerosis Drugs Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Multiple Sclerosis Drugs Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Multiple Sclerosis Drugs Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Multiple Sclerosis Drugs Treatment Market Perspective (2015-2026)
2.2 Multiple Sclerosis Drugs Treatment Growth Trends by Regions
  2.2.1 Multiple Sclerosis Drugs Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Multiple Sclerosis Drugs Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Multiple Sclerosis Drugs Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Multiple Sclerosis Drugs Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Multiple Sclerosis Drugs Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Multiple Sclerosis Drugs Treatment Players by Market Size
  3.1.1 Global Top Multiple Sclerosis Drugs Treatment Players by Revenue (2015-2020)
  3.1.2 Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Multiple Sclerosis Drugs Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Multiple Sclerosis Drugs Treatment Market Concentration Ratio
  3.2.1 Global Multiple Sclerosis Drugs Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Multiple Sclerosis Drugs Treatment Revenue in 2019
3.3 Multiple Sclerosis Drugs Treatment Key Players Head office and Area Served
3.4 Key Players Multiple Sclerosis Drugs Treatment Product Solution and Service
3.5 Date of Enter into Multiple Sclerosis Drugs Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Multiple Sclerosis Drugs Treatment Historic Market Size by Type (2015-2020)
4.2 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Type (2021-2026)

5 MULTIPLE SCLEROSIS DRUGS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)
5.2 Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Multiple Sclerosis Drugs Treatment Market Size (2015-2020)
6.2 Multiple Sclerosis Drugs Treatment Key Players in North America (2019-2020)
6.3 North America Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020)
6.4 North America Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Multiple Sclerosis Drugs Treatment Market Size (2015-2020)
7.2 Multiple Sclerosis Drugs Treatment Key Players in Europe (2019-2020)
7.3 Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020)
7.4 Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Multiple Sclerosis Drugs Treatment Market Size (2015-2020)
8.2 Multiple Sclerosis Drugs Treatment Key Players in China (2019-2020)
8.3 China Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020)
8.4 China Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Multiple Sclerosis Drugs Treatment Market Size (2015-2020)
9.2 Multiple Sclerosis Drugs Treatment Key Players in Japan (2019-2020)
9.3 Japan Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020)
9.4 Japan Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Multiple Sclerosis Drugs Treatment Market Size (2015-2020)
10.2 Multiple Sclerosis Drugs Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Multiple Sclerosis Drugs Treatment Market Size (2015-2020)
11.2 Multiple Sclerosis Drugs Treatment Key Players in India (2019-2020)
11.3 India Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020)
11.4 India Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Multiple Sclerosis Drugs Treatment Market Size (2015-2020)
12.2 Multiple Sclerosis Drugs Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020)
12.4 Central & South America Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Multiple Sclerosis Drugs Treatment Introduction
  13.1.4 Pfizer Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche Multiple Sclerosis Drugs Treatment Introduction
  13.2.4 Roche Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 Biogen
  13.3.1 Biogen Company Details
  13.3.2 Biogen Business Overview and Its Total Revenue
  13.3.3 Biogen Multiple Sclerosis Drugs Treatment Introduction
  13.3.4 Biogen Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020)
  13.3.5 Biogen Recent Development
13.4 Teva Pharmaceutical
  13.4.1 Teva Pharmaceutical Company Details
  13.4.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  13.4.3 Teva Pharmaceutical Multiple Sclerosis Drugs Treatment Introduction
  13.4.4 Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020)
  13.4.5 Teva Pharmaceutical Recent Development
13.5 Merck
  13.5.1 Merck Company Details
  13.5.2 Merck Business Overview and Its Total Revenue
  13.5.3 Merck Multiple Sclerosis Drugs Treatment Introduction
  13.5.4 Merck Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020)
  13.5.5 Merck Recent Development
13.6 Novartis
  13.6.1 Novartis Company Details
  13.6.2 Novartis Business Overview and Its Total Revenue
  13.6.3 Novartis Multiple Sclerosis Drugs Treatment Introduction
  13.6.4 Novartis Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020)
  13.6.5 Novartis Recent Development
13.7 Bayer
  13.7.1 Bayer Company Details
  13.7.2 Bayer Business Overview and Its Total Revenue
  13.7.3 Bayer Multiple Sclerosis Drugs Treatment Introduction
  13.7.4 Bayer Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020)
  13.7.5 Bayer Recent Development
13.8 Sanofi
  13.8.1 Sanofi Company Details
  13.8.2 Sanofi Business Overview and Its Total Revenue
  13.8.3 Sanofi Multiple Sclerosis Drugs Treatment Introduction
  13.8.4 Sanofi Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020)
  13.8.5 Sanofi Recent Development
13.9 Acorda Therapeutics
  13.9.1 Acorda Therapeutics Company Details
  13.9.2 Acorda Therapeutics Business Overview and Its Total Revenue
  13.9.3 Acorda Therapeutics Multiple Sclerosis Drugs Treatment Introduction
  13.9.4 Acorda Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020)
  13.9.5 Acorda Therapeutics Recent Development
13.10 Questcor Pharmaceuticals
  13.10.1 Questcor Pharmaceuticals Company Details
  13.10.2 Questcor Pharmaceuticals Business Overview and Its Total Revenue
  13.10.3 Questcor Pharmaceuticals Multiple Sclerosis Drugs Treatment Introduction
  13.10.4 Questcor Pharmaceuticals Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020)
  13.10.5 Questcor Pharmaceuticals Recent Development
13.11 AbbVie
  10.11.1 AbbVie Company Details
  10.11.2 AbbVie Business Overview and Its Total Revenue
  10.11.3 AbbVie Multiple Sclerosis Drugs Treatment Introduction
  10.11.4 AbbVie Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020)
  10.11.5 AbbVie Recent Development
13.12 Opexa Therapeutics
  10.12.1 Opexa Therapeutics Company Details
  10.12.2 Opexa Therapeutics Business Overview and Its Total Revenue
  10.12.3 Opexa Therapeutics Multiple Sclerosis Drugs Treatment Introduction
  10.12.4 Opexa Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020)
  10.12.5 Opexa Therapeutics Recent Development
13.13 Genzyme Corporation
  10.13.1 Genzyme Corporation Company Details
  10.13.2 Genzyme Corporation Business Overview and Its Total Revenue
  10.13.3 Genzyme Corporation Multiple Sclerosis Drugs Treatment Introduction
  10.13.4 Genzyme Corporation Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020)
  10.13.5 Genzyme Corporation Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Multiple Sclerosis Drugs Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Multiple Sclerosis Drugs Treatment Revenue
Table 3. Ranking of Global Top Multiple Sclerosis Drugs Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Multiple Sclerosis Drugs Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Interferon
Table 6. Key Players of Immunomodulator
Table 7. Key Players of Immunosuppressant
Table 8. COVID-19 Impact Global Market: (Four Multiple Sclerosis Drugs Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Multiple Sclerosis Drugs Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Multiple Sclerosis Drugs Treatment Players to Combat Covid-19 Impact
Table 13. Global Multiple Sclerosis Drugs Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Multiple Sclerosis Drugs Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Multiple Sclerosis Drugs Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Multiple Sclerosis Drugs Treatment Market Share by Regions (2015-2020)
Table 17. Global Multiple Sclerosis Drugs Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Multiple Sclerosis Drugs Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Multiple Sclerosis Drugs Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Multiple Sclerosis Drugs Treatment Players
Table 24. Global Multiple Sclerosis Drugs Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Multiple Sclerosis Drugs Treatment Market Share by Players (2015-2020)
Table 26. Global Top Multiple Sclerosis Drugs Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Sclerosis Drugs Treatment as of 2019)
Table 27. Global Multiple Sclerosis Drugs Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Multiple Sclerosis Drugs Treatment Product Solution and Service
Table 30. Date of Enter into Multiple Sclerosis Drugs Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Multiple Sclerosis Drugs Treatment Market Size Share by Type (2015-2020)
Table 34. Global Multiple Sclerosis Drugs Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Multiple Sclerosis Drugs Treatment Market Size Share by Application (2015-2020)
Table 36. Global Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Multiple Sclerosis Drugs Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Multiple Sclerosis Drugs Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Multiple Sclerosis Drugs Treatment Market Share (2019-2020)
Table 40. North America Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Multiple Sclerosis Drugs Treatment Market Share by Type (2015-2020)
Table 42. North America Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Multiple Sclerosis Drugs Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Multiple Sclerosis Drugs Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Multiple Sclerosis Drugs Treatment Market Share (2019-2020)
Table 46. Europe Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Multiple Sclerosis Drugs Treatment Market Share by Type (2015-2020)
Table 48. Europe Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Multiple Sclerosis Drugs Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Multiple Sclerosis Drugs Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Multiple Sclerosis Drugs Treatment Market Share (2019-2020)
Table 52. China Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Multiple Sclerosis Drugs Treatment Market Share by Type (2015-2020)
Table 54. China Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Multiple Sclerosis Drugs Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Multiple Sclerosis Drugs Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Multiple Sclerosis Drugs Treatment Market Share (2019-2020)
Table 58. Japan Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Multiple Sclerosis Drugs Treatment Market Share by Type (2015-2020)
Table 60. Japan Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Multiple Sclerosis Drugs Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Multiple Sclerosis Drugs Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Multiple Sclerosis Drugs Treatment Market Share (2019-2020)
Table 64. Southeast Asia Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Multiple Sclerosis Drugs Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Multiple Sclerosis Drugs Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Multiple Sclerosis Drugs Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Multiple Sclerosis Drugs Treatment Market Share (2019-2020)
Table 70. India Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Multiple Sclerosis Drugs Treatment Market Share by Type (2015-2020)
Table 72. India Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Multiple Sclerosis Drugs Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Multiple Sclerosis Drugs Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Multiple Sclerosis Drugs Treatment Market Share (2019-2020)
Table 76. Central & South America Multiple Sclerosis Drugs Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Multiple Sclerosis Drugs Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Multiple Sclerosis Drugs Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Multiple Sclerosis Drugs Treatment Market Share by Application (2015-2020)
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Product
Table 88. Roche Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 89. Roche Recent Development
Table 90. Biogen Company Details
Table 91. Biogen Business Overview
Table 92. Biogen Product
Table 93. Biogen Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 94. Biogen Recent Development
Table 95. Teva Pharmaceutical Company Details
Table 96. Teva Pharmaceutical Business Overview
Table 97. Teva Pharmaceutical Product
Table 98. Teva Pharmaceutical Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 99. Teva Pharmaceutical Recent Development
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Product
Table 103. Merck Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 104. Merck Recent Development
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Product
Table 108. Novartis Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 109. Novartis Recent Development
Table 110. Bayer Company Details
Table 111. Bayer Business Overview
Table 112. Bayer Product
Table 113. Bayer Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 114. Bayer Recent Development
Table 115. Sanofi Business Overview
Table 116. Sanofi Product
Table 117. Sanofi Company Details
Table 118. Sanofi Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 119. Sanofi Recent Development
Table 120. Acorda Therapeutics Company Details
Table 121. Acorda Therapeutics Business Overview
Table 122. Acorda Therapeutics Product
Table 123. Acorda Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 124. Acorda Therapeutics Recent Development
Table 125. Questcor Pharmaceuticals Company Details
Table 126. Questcor Pharmaceuticals Business Overview
Table 127. Questcor Pharmaceuticals Product
Table 128. Questcor Pharmaceuticals Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 129. Questcor Pharmaceuticals Recent Development
Table 130. AbbVie Company Details
Table 131. AbbVie Business Overview
Table 132. AbbVie Product
Table 133. AbbVie Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 134. AbbVie Recent Development
Table 135. Opexa Therapeutics Company Details
Table 136. Opexa Therapeutics Business Overview
Table 137. Opexa Therapeutics Product
Table 138. Opexa Therapeutics Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 139. Opexa Therapeutics Recent Development
Table 140. Genzyme Corporation Company Details
Table 141. Genzyme Corporation Business Overview
Table 142. Genzyme Corporation Product
Table 143. Genzyme Corporation Revenue in Multiple Sclerosis Drugs Treatment Business (2015-2020) (Million US$)
Table 144. Genzyme Corporation Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Multiple Sclerosis Drugs Treatment Market Share by Type: 2020 VS 2026
Figure 2. Interferon Features
Figure 3. Immunomodulator Features
Figure 4. Immunosuppressant Features
Figure 5. Global Multiple Sclerosis Drugs Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Multiple Sclerosis Drugs Treatment Report Years Considered
Figure 11. Global Multiple Sclerosis Drugs Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Multiple Sclerosis Drugs Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Multiple Sclerosis Drugs Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Multiple Sclerosis Drugs Treatment Market Share by Players in 2019
Figure 16. Global Top Multiple Sclerosis Drugs Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Sclerosis Drugs Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Multiple Sclerosis Drugs Treatment Revenue in 2019
Figure 18. North America Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Multiple Sclerosis Drugs Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 27. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Roche Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 29. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Biogen Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 31. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Teva Pharmaceutical Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 33. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Merck Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 35. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Novartis Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 37. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Bayer Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 39. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Sanofi Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 41. Acorda Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Acorda Therapeutics Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 43. Questcor Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Questcor Pharmaceuticals Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 45. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. AbbVie Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 47. Opexa Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Opexa Therapeutics Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 49. Genzyme Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Genzyme Corporation Revenue Growth Rate in Multiple Sclerosis Drugs Treatment Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed